Your browser doesn't support javascript.
loading
Efficacy and safety of ipragliflozin and metformin for visceral fat reduction in patients with type 2 diabetes receiving treatment with dipeptidyl peptidase-4 inhibitors in Japan: a study protocol for a prospective, multicentre, blinded-endpoint phase IV randomised controlled trial (PRIME-V study).
Koshizaka, Masaya; Ishikawa, Ko; Ishikawa, Takahiro; Kobayashi, Kazuki; Takemoto, Minoru; Horikoshi, Takuro; Shimofusa, Ryota; Takahashi, Sho; Nagashima, Kengo; Sato, Yasunori; Tatsuno, Ichiro; Terano, Takashi; Hashimoto, Naotake; Kuribayashi, Nobuichi; Uchida, Daigaku; Yokote, Koutaro.
Afiliación
  • Koshizaka M; Department of Diabetes, Metabolism and Endocrinology, Chiba University, Chiba, Japan.
  • Ishikawa K; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Ishikawa T; Department of Diabetes, Metabolism and Endocrinology, Chiba University, Chiba, Japan.
  • Kobayashi K; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Takemoto M; Department of Diabetes, Metabolism and Endocrinology, Chiba University, Chiba, Japan.
  • Horikoshi T; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Shimofusa R; Department of Diabetes, Metabolism and Endocrinology, Chiba University, Chiba, Japan.
  • Takahashi S; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Nagashima K; Department of Diabetes, Metabolism and Endocrinology, Chiba University, Chiba, Japan.
  • Sato Y; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Tatsuno I; Diagnostic Radiology and Radiation Oncology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Terano T; Department of Radiology, Sannou Hospital, Chiba, Japan.
  • Hashimoto N; Clinical Research Center, Chiba University Hospital, Chiba, Japan.
  • Kuribayashi N; Department of Global Clinical Research, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Uchida D; Department of Global Clinical Research, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Yokote K; Center of Diabetes, Endocrinology and Metabolism, Toho University Sakura Medical Center, Sakura, Japan.
BMJ Open ; 7(5): e015766, 2017 05 09.
Article en En | MEDLINE | ID: mdl-28490565
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials / Guideline / Observational_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMJ Open Año: 2017 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 Problema de salud: 1_doencas_nao_transmissiveis / 2_muertes_prematuras_enfermedades_notrasmisibles Asunto principal: Tiofenos / Diabetes Mellitus Tipo 2 / Inhibidores del Cotransportador de Sodio-Glucosa 2 / Glucósidos / Hipoglucemiantes / Metformina Tipo de estudio: Clinical_trials / Guideline / Observational_studies Aspecto: Ethics Límite: Humans País/Región como asunto: Asia Idioma: En Revista: BMJ Open Año: 2017 Tipo del documento: Article País de afiliación: Japón